nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—epilepsy syndrome	0.245	1	CbGaD
Nilutamide—CYP2C8—Trimethadione—epilepsy syndrome	0.0301	0.0554	CbGbCtD
Nilutamide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0283	0.0521	CbGbCtD
Nilutamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0272	0.05	CbGbCtD
Nilutamide—CYP2C19—Felbamate—epilepsy syndrome	0.0253	0.0465	CbGbCtD
Nilutamide—CYP2C19—Trimethadione—epilepsy syndrome	0.0253	0.0465	CbGbCtD
Nilutamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0238	0.0437	CbGbCtD
Nilutamide—CYP2C9—Trimethadione—epilepsy syndrome	0.021	0.0387	CbGbCtD
Nilutamide—CYP2C19—Clobazam—epilepsy syndrome	0.0206	0.0379	CbGbCtD
Nilutamide—CYP2C8—Carbamazepine—epilepsy syndrome	0.0204	0.0374	CbGbCtD
Nilutamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0198	0.0363	CbGbCtD
Nilutamide—CYP2C8—Primidone—epilepsy syndrome	0.019	0.0349	CbGbCtD
Nilutamide—CYP2C8—Phenytoin—epilepsy syndrome	0.0183	0.0336	CbGbCtD
Nilutamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.0171	0.0314	CbGbCtD
Nilutamide—CYP2C8—Propofol—epilepsy syndrome	0.017	0.0313	CbGbCtD
Nilutamide—CYP2C8—Phenobarbital—epilepsy syndrome	0.0163	0.0299	CbGbCtD
Nilutamide—CYP2C19—Primidone—epilepsy syndrome	0.0159	0.0293	CbGbCtD
Nilutamide—CYP2C8—Diazepam—epilepsy syndrome	0.0154	0.0284	CbGbCtD
Nilutamide—CYP2C19—Phenytoin—epilepsy syndrome	0.0153	0.0282	CbGbCtD
Nilutamide—CYP2C19—Propofol—epilepsy syndrome	0.0143	0.0263	CbGbCtD
Nilutamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0142	0.0261	CbGbCtD
Nilutamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.0137	0.0251	CbGbCtD
Nilutamide—CYP2C9—Primidone—epilepsy syndrome	0.0133	0.0244	CbGbCtD
Nilutamide—CYP2C19—Diazepam—epilepsy syndrome	0.0129	0.0238	CbGbCtD
Nilutamide—CYP2C9—Phenytoin—epilepsy syndrome	0.0127	0.0234	CbGbCtD
Nilutamide—CYP2C19—Zonisamide—epilepsy syndrome	0.0126	0.0232	CbGbCtD
Nilutamide—CYP2C8—Valproic Acid—epilepsy syndrome	0.0122	0.0224	CbGbCtD
Nilutamide—CYP2C9—Propofol—epilepsy syndrome	0.0119	0.0218	CbGbCtD
Nilutamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0114	0.0209	CbGbCtD
Nilutamide—CYP2C9—Diazepam—epilepsy syndrome	0.0108	0.0198	CbGbCtD
Nilutamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.0102	0.0188	CbGbCtD
Nilutamide—CYP2C19—Topiramate—epilepsy syndrome	0.00921	0.0169	CbGbCtD
Nilutamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00848	0.0156	CbGbCtD
Nilutamide—Flutamide—CYP2C19—epilepsy syndrome	0.000735	0.279	CrCbGaD
Nilutamide—Enzalutamide—CYP2C19—epilepsy syndrome	0.000672	0.255	CrCbGaD
Nilutamide—Enzalutamide—CYP2D6—epilepsy syndrome	0.000499	0.189	CrCbGaD
Nilutamide—Enzalutamide—ALB—epilepsy syndrome	0.000373	0.142	CrCbGaD
Nilutamide—Enzalutamide—ABCB1—epilepsy syndrome	0.000356	0.135	CrCbGaD
Nilutamide—Headache—Propofol—epilepsy syndrome	0.000104	0.000578	CcSEcCtD
Nilutamide—Vomiting—Midazolam—epilepsy syndrome	0.000103	0.000574	CcSEcCtD
Nilutamide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000103	0.000574	CcSEcCtD
Nilutamide—Asthenia—Felbamate—epilepsy syndrome	0.000103	0.000573	CcSEcCtD
Nilutamide—Chest pain—Valproic Acid—epilepsy syndrome	0.000103	0.000573	CcSEcCtD
Nilutamide—Haematuria—Topiramate—epilepsy syndrome	0.000103	0.000572	CcSEcCtD
Nilutamide—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000102	0.000569	CcSEcCtD
Nilutamide—Rash—Midazolam—epilepsy syndrome	0.000102	0.000569	CcSEcCtD
Nilutamide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000102	0.000569	CcSEcCtD
Nilutamide—Dermatitis—Midazolam—epilepsy syndrome	0.000102	0.000569	CcSEcCtD
Nilutamide—Vomiting—Levetiracetam—epilepsy syndrome	0.000102	0.000567	CcSEcCtD
Nilutamide—Alopecia—Gabapentin—epilepsy syndrome	0.000102	0.000566	CcSEcCtD
Nilutamide—Discomfort—Valproic Acid—epilepsy syndrome	0.000102	0.000566	CcSEcCtD
Nilutamide—Headache—Midazolam—epilepsy syndrome	0.000102	0.000566	CcSEcCtD
Nilutamide—Pruritus—Felbamate—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Nilutamide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Nilutamide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Nilutamide—Diarrhoea—Diazepam—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Nilutamide—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000101	0.000564	CcSEcCtD
Nilutamide—Rash—Levetiracetam—epilepsy syndrome	0.000101	0.000562	CcSEcCtD
Nilutamide—Anaemia—Pregabalin—epilepsy syndrome	0.000101	0.000562	CcSEcCtD
Nilutamide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000101	0.000562	CcSEcCtD
Nilutamide—Asthenia—Zonisamide—epilepsy syndrome	0.000101	0.000561	CcSEcCtD
Nilutamide—Dry mouth—Valproic Acid—epilepsy syndrome	0.000101	0.00056	CcSEcCtD
Nilutamide—Headache—Levetiracetam—epilepsy syndrome	0.0001	0.000559	CcSEcCtD
Nilutamide—Dizziness—Vigabatrin—epilepsy syndrome	9.97e-05	0.000555	CcSEcCtD
Nilutamide—Pruritus—Zonisamide—epilepsy syndrome	9.95e-05	0.000553	CcSEcCtD
Nilutamide—Oedema—Valproic Acid—epilepsy syndrome	9.87e-05	0.000549	CcSEcCtD
Nilutamide—Malaise—Pregabalin—epilepsy syndrome	9.86e-05	0.000548	CcSEcCtD
Nilutamide—Nausea—Propofol—epilepsy syndrome	9.85e-05	0.000548	CcSEcCtD
Nilutamide—Tension—Gabapentin—epilepsy syndrome	9.84e-05	0.000547	CcSEcCtD
Nilutamide—Vomiting—Fosphenytoin—epilepsy syndrome	9.83e-05	0.000547	CcSEcCtD
Nilutamide—Diarrhoea—Felbamate—epilepsy syndrome	9.83e-05	0.000547	CcSEcCtD
Nilutamide—Body temperature increased—Lamotrigine—epilepsy syndrome	9.82e-05	0.000546	CcSEcCtD
Nilutamide—Abdominal pain—Lamotrigine—epilepsy syndrome	9.82e-05	0.000546	CcSEcCtD
Nilutamide—Dizziness—Diazepam—epilepsy syndrome	9.81e-05	0.000546	CcSEcCtD
Nilutamide—Syncope—Pregabalin—epilepsy syndrome	9.8e-05	0.000545	CcSEcCtD
Nilutamide—Leukopenia—Pregabalin—epilepsy syndrome	9.78e-05	0.000544	CcSEcCtD
Nilutamide—Rash—Fosphenytoin—epilepsy syndrome	9.75e-05	0.000543	CcSEcCtD
Nilutamide—Dermatitis—Fosphenytoin—epilepsy syndrome	9.74e-05	0.000542	CcSEcCtD
Nilutamide—Nervousness—Gabapentin—epilepsy syndrome	9.73e-05	0.000542	CcSEcCtD
Nilutamide—Asthenia—Clonazepam—epilepsy syndrome	9.72e-05	0.000541	CcSEcCtD
Nilutamide—Rhinitis—Topiramate—epilepsy syndrome	9.71e-05	0.00054	CcSEcCtD
Nilutamide—Back pain—Gabapentin—epilepsy syndrome	9.69e-05	0.000539	CcSEcCtD
Nilutamide—Headache—Fosphenytoin—epilepsy syndrome	9.69e-05	0.000539	CcSEcCtD
Nilutamide—Asthenia—Phenytoin—epilepsy syndrome	9.66e-05	0.000537	CcSEcCtD
Nilutamide—Nausea—Midazolam—epilepsy syndrome	9.64e-05	0.000536	CcSEcCtD
Nilutamide—Hypoaesthesia—Topiramate—epilepsy syndrome	9.64e-05	0.000536	CcSEcCtD
Nilutamide—Diarrhoea—Zonisamide—epilepsy syndrome	9.62e-05	0.000535	CcSEcCtD
Nilutamide—Loss of consciousness—Pregabalin—epilepsy syndrome	9.61e-05	0.000534	CcSEcCtD
Nilutamide—Asthenia—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000534	CcSEcCtD
Nilutamide—Pruritus—Clonazepam—epilepsy syndrome	9.59e-05	0.000533	CcSEcCtD
Nilutamide—Vomiting—Vigabatrin—epilepsy syndrome	9.58e-05	0.000533	CcSEcCtD
Nilutamide—Urinary tract disorder—Topiramate—epilepsy syndrome	9.57e-05	0.000532	CcSEcCtD
Nilutamide—Oedema peripheral—Topiramate—epilepsy syndrome	9.54e-05	0.000531	CcSEcCtD
Nilutamide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.54e-05	0.000531	CcSEcCtD
Nilutamide—Cough—Pregabalin—epilepsy syndrome	9.54e-05	0.000531	CcSEcCtD
Nilutamide—Pruritus—Phenytoin—epilepsy syndrome	9.52e-05	0.00053	CcSEcCtD
Nilutamide—Nausea—Levetiracetam—epilepsy syndrome	9.52e-05	0.00053	CcSEcCtD
Nilutamide—Rash—Vigabatrin—epilepsy syndrome	9.5e-05	0.000529	CcSEcCtD
Nilutamide—Dizziness—Felbamate—epilepsy syndrome	9.5e-05	0.000528	CcSEcCtD
Nilutamide—Dermatitis—Vigabatrin—epilepsy syndrome	9.5e-05	0.000528	CcSEcCtD
Nilutamide—Urethral disorder—Topiramate—epilepsy syndrome	9.5e-05	0.000528	CcSEcCtD
Nilutamide—Pruritus—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.000527	CcSEcCtD
Nilutamide—Headache—Vigabatrin—epilepsy syndrome	9.44e-05	0.000525	CcSEcCtD
Nilutamide—Hypertension—Pregabalin—epilepsy syndrome	9.44e-05	0.000525	CcSEcCtD
Nilutamide—Vomiting—Diazepam—epilepsy syndrome	9.44e-05	0.000525	CcSEcCtD
Nilutamide—Anorexia—Valproic Acid—epilepsy syndrome	9.41e-05	0.000523	CcSEcCtD
Nilutamide—Rash—Diazepam—epilepsy syndrome	9.36e-05	0.000521	CcSEcCtD
Nilutamide—Dermatitis—Diazepam—epilepsy syndrome	9.35e-05	0.00052	CcSEcCtD
Nilutamide—Visual impairment—Topiramate—epilepsy syndrome	9.33e-05	0.000519	CcSEcCtD
Nilutamide—Chest pain—Pregabalin—epilepsy syndrome	9.31e-05	0.000518	CcSEcCtD
Nilutamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.3e-05	0.000517	CcSEcCtD
Nilutamide—Dizziness—Zonisamide—epilepsy syndrome	9.3e-05	0.000517	CcSEcCtD
Nilutamide—Headache—Diazepam—epilepsy syndrome	9.3e-05	0.000517	CcSEcCtD
Nilutamide—Diarrhoea—Clonazepam—epilepsy syndrome	9.27e-05	0.000516	CcSEcCtD
Nilutamide—Anaemia—Gabapentin—epilepsy syndrome	9.26e-05	0.000515	CcSEcCtD
Nilutamide—Asthenia—Carbamazepine—epilepsy syndrome	9.22e-05	0.000513	CcSEcCtD
Nilutamide—Diarrhoea—Phenytoin—epilepsy syndrome	9.21e-05	0.000512	CcSEcCtD
Nilutamide—Discomfort—Pregabalin—epilepsy syndrome	9.19e-05	0.000512	CcSEcCtD
Nilutamide—Nausea—Fosphenytoin—epilepsy syndrome	9.19e-05	0.000511	CcSEcCtD
Nilutamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.16e-05	0.00051	CcSEcCtD
Nilutamide—Vomiting—Felbamate—epilepsy syndrome	9.13e-05	0.000508	CcSEcCtD
Nilutamide—Dry mouth—Pregabalin—epilepsy syndrome	9.1e-05	0.000506	CcSEcCtD
Nilutamide—Pruritus—Carbamazepine—epilepsy syndrome	9.09e-05	0.000506	CcSEcCtD
Nilutamide—Rash—Felbamate—epilepsy syndrome	9.06e-05	0.000504	CcSEcCtD
Nilutamide—Dermatitis—Felbamate—epilepsy syndrome	9.05e-05	0.000503	CcSEcCtD
Nilutamide—Malaise—Gabapentin—epilepsy syndrome	9.04e-05	0.000503	CcSEcCtD
Nilutamide—Headache—Felbamate—epilepsy syndrome	9e-05	0.000501	CcSEcCtD
Nilutamide—Syncope—Gabapentin—epilepsy syndrome	8.99e-05	0.0005	CcSEcCtD
Nilutamide—Leukopenia—Gabapentin—epilepsy syndrome	8.97e-05	0.000499	CcSEcCtD
Nilutamide—Dizziness—Clonazepam—epilepsy syndrome	8.96e-05	0.000499	CcSEcCtD
Nilutamide—Nausea—Vigabatrin—epilepsy syndrome	8.95e-05	0.000498	CcSEcCtD
Nilutamide—Vomiting—Zonisamide—epilepsy syndrome	8.94e-05	0.000497	CcSEcCtD
Nilutamide—Insomnia—Valproic Acid—epilepsy syndrome	8.92e-05	0.000497	CcSEcCtD
Nilutamide—Oedema—Pregabalin—epilepsy syndrome	8.92e-05	0.000496	CcSEcCtD
Nilutamide—Asthenia—Lamotrigine—epilepsy syndrome	8.91e-05	0.000496	CcSEcCtD
Nilutamide—Dizziness—Phenytoin—epilepsy syndrome	8.9e-05	0.000495	CcSEcCtD
Nilutamide—Rash—Zonisamide—epilepsy syndrome	8.87e-05	0.000493	CcSEcCtD
Nilutamide—Paraesthesia—Valproic Acid—epilepsy syndrome	8.86e-05	0.000493	CcSEcCtD
Nilutamide—Dermatitis—Zonisamide—epilepsy syndrome	8.86e-05	0.000493	CcSEcCtD
Nilutamide—Dizziness—Oxcarbazepine—epilepsy syndrome	8.85e-05	0.000493	CcSEcCtD
Nilutamide—Nausea—Diazepam—epilepsy syndrome	8.82e-05	0.00049	CcSEcCtD
Nilutamide—Loss of consciousness—Gabapentin—epilepsy syndrome	8.81e-05	0.00049	CcSEcCtD
Nilutamide—Headache—Zonisamide—epilepsy syndrome	8.81e-05	0.00049	CcSEcCtD
Nilutamide—Dyspnoea—Valproic Acid—epilepsy syndrome	8.8e-05	0.000489	CcSEcCtD
Nilutamide—Diarrhoea—Carbamazepine—epilepsy syndrome	8.79e-05	0.000489	CcSEcCtD
Nilutamide—Pruritus—Lamotrigine—epilepsy syndrome	8.79e-05	0.000489	CcSEcCtD
Nilutamide—Shock—Pregabalin—epilepsy syndrome	8.78e-05	0.000488	CcSEcCtD
Nilutamide—Cough—Gabapentin—epilepsy syndrome	8.75e-05	0.000487	CcSEcCtD
Nilutamide—Dyspepsia—Valproic Acid—epilepsy syndrome	8.69e-05	0.000483	CcSEcCtD
Nilutamide—Hypertension—Gabapentin—epilepsy syndrome	8.65e-05	0.000481	CcSEcCtD
Nilutamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.62e-05	0.00048	CcSEcCtD
Nilutamide—Vomiting—Clonazepam—epilepsy syndrome	8.62e-05	0.000479	CcSEcCtD
Nilutamide—Decreased appetite—Valproic Acid—epilepsy syndrome	8.58e-05	0.000477	CcSEcCtD
Nilutamide—Alopecia—Topiramate—epilepsy syndrome	8.56e-05	0.000476	CcSEcCtD
Nilutamide—Vomiting—Phenytoin—epilepsy syndrome	8.56e-05	0.000476	CcSEcCtD
Nilutamide—Rash—Clonazepam—epilepsy syndrome	8.54e-05	0.000475	CcSEcCtD
Nilutamide—Dermatitis—Clonazepam—epilepsy syndrome	8.54e-05	0.000475	CcSEcCtD
Nilutamide—Chest pain—Gabapentin—epilepsy syndrome	8.53e-05	0.000475	CcSEcCtD
Nilutamide—Nausea—Felbamate—epilepsy syndrome	8.53e-05	0.000475	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.52e-05	0.000474	CcSEcCtD
Nilutamide—Vomiting—Oxcarbazepine—epilepsy syndrome	8.51e-05	0.000474	CcSEcCtD
Nilutamide—Anorexia—Pregabalin—epilepsy syndrome	8.5e-05	0.000473	CcSEcCtD
Nilutamide—Dizziness—Carbamazepine—epilepsy syndrome	8.5e-05	0.000473	CcSEcCtD
Nilutamide—Diarrhoea—Lamotrigine—epilepsy syndrome	8.5e-05	0.000473	CcSEcCtD
Nilutamide—Headache—Clonazepam—epilepsy syndrome	8.49e-05	0.000472	CcSEcCtD
Nilutamide—Rash—Phenytoin—epilepsy syndrome	8.49e-05	0.000472	CcSEcCtD
Nilutamide—Dermatitis—Phenytoin—epilepsy syndrome	8.48e-05	0.000472	CcSEcCtD
Nilutamide—Rash—Oxcarbazepine—epilepsy syndrome	8.44e-05	0.00047	CcSEcCtD
Nilutamide—Pain—Valproic Acid—epilepsy syndrome	8.44e-05	0.000469	CcSEcCtD
Nilutamide—Constipation—Valproic Acid—epilepsy syndrome	8.44e-05	0.000469	CcSEcCtD
Nilutamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.43e-05	0.000469	CcSEcCtD
Nilutamide—Headache—Phenytoin—epilepsy syndrome	8.43e-05	0.000469	CcSEcCtD
Nilutamide—Discomfort—Gabapentin—epilepsy syndrome	8.43e-05	0.000469	CcSEcCtD
Nilutamide—Headache—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000467	CcSEcCtD
Nilutamide—Nausea—Zonisamide—epilepsy syndrome	8.35e-05	0.000465	CcSEcCtD
Nilutamide—Dry mouth—Gabapentin—epilepsy syndrome	8.35e-05	0.000464	CcSEcCtD
Nilutamide—Tension—Topiramate—epilepsy syndrome	8.27e-05	0.00046	CcSEcCtD
Nilutamide—Dizziness—Lamotrigine—epilepsy syndrome	8.21e-05	0.000457	CcSEcCtD
Nilutamide—Nervousness—Topiramate—epilepsy syndrome	8.19e-05	0.000456	CcSEcCtD
Nilutamide—Oedema—Gabapentin—epilepsy syndrome	8.18e-05	0.000455	CcSEcCtD
Nilutamide—Vomiting—Carbamazepine—epilepsy syndrome	8.17e-05	0.000455	CcSEcCtD
Nilutamide—Back pain—Topiramate—epilepsy syndrome	8.16e-05	0.000454	CcSEcCtD
Nilutamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.13e-05	0.000452	CcSEcCtD
Nilutamide—Rash—Carbamazepine—epilepsy syndrome	8.1e-05	0.000451	CcSEcCtD
Nilutamide—Dermatitis—Carbamazepine—epilepsy syndrome	8.09e-05	0.00045	CcSEcCtD
Nilutamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.07e-05	0.000449	CcSEcCtD
Nilutamide—Insomnia—Pregabalin—epilepsy syndrome	8.07e-05	0.000449	CcSEcCtD
Nilutamide—Nausea—Clonazepam—epilepsy syndrome	8.05e-05	0.000448	CcSEcCtD
Nilutamide—Headache—Carbamazepine—epilepsy syndrome	8.05e-05	0.000448	CcSEcCtD
Nilutamide—Shock—Gabapentin—epilepsy syndrome	8.05e-05	0.000448	CcSEcCtD
Nilutamide—Paraesthesia—Pregabalin—epilepsy syndrome	8.01e-05	0.000446	CcSEcCtD
Nilutamide—Nausea—Phenytoin—epilepsy syndrome	8e-05	0.000445	CcSEcCtD
Nilutamide—Dyspnoea—Pregabalin—epilepsy syndrome	7.95e-05	0.000442	CcSEcCtD
Nilutamide—Nausea—Oxcarbazepine—epilepsy syndrome	7.95e-05	0.000442	CcSEcCtD
Nilutamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.91e-05	0.00044	CcSEcCtD
Nilutamide—Vomiting—Lamotrigine—epilepsy syndrome	7.9e-05	0.000439	CcSEcCtD
Nilutamide—Rash—Lamotrigine—epilepsy syndrome	7.83e-05	0.000436	CcSEcCtD
Nilutamide—Ill-defined disorder—Topiramate—epilepsy syndrome	7.82e-05	0.000435	CcSEcCtD
Nilutamide—Dermatitis—Lamotrigine—epilepsy syndrome	7.82e-05	0.000435	CcSEcCtD
Nilutamide—Body temperature increased—Valproic Acid—epilepsy syndrome	7.8e-05	0.000434	CcSEcCtD
Nilutamide—Abdominal pain—Valproic Acid—epilepsy syndrome	7.8e-05	0.000434	CcSEcCtD
Nilutamide—Anorexia—Gabapentin—epilepsy syndrome	7.8e-05	0.000434	CcSEcCtD
Nilutamide—Anaemia—Topiramate—epilepsy syndrome	7.79e-05	0.000434	CcSEcCtD
Nilutamide—Headache—Lamotrigine—epilepsy syndrome	7.78e-05	0.000433	CcSEcCtD
Nilutamide—Decreased appetite—Pregabalin—epilepsy syndrome	7.75e-05	0.000431	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.7e-05	0.000428	CcSEcCtD
Nilutamide—Nausea—Carbamazepine—epilepsy syndrome	7.63e-05	0.000425	CcSEcCtD
Nilutamide—Constipation—Pregabalin—epilepsy syndrome	7.63e-05	0.000424	CcSEcCtD
Nilutamide—Pain—Pregabalin—epilepsy syndrome	7.63e-05	0.000424	CcSEcCtD
Nilutamide—Malaise—Topiramate—epilepsy syndrome	7.6e-05	0.000423	CcSEcCtD
Nilutamide—Syncope—Topiramate—epilepsy syndrome	7.56e-05	0.000421	CcSEcCtD
Nilutamide—Leukopenia—Topiramate—epilepsy syndrome	7.55e-05	0.00042	CcSEcCtD
Nilutamide—Loss of consciousness—Topiramate—epilepsy syndrome	7.41e-05	0.000412	CcSEcCtD
Nilutamide—Insomnia—Gabapentin—epilepsy syndrome	7.4e-05	0.000412	CcSEcCtD
Nilutamide—Nausea—Lamotrigine—epilepsy syndrome	7.38e-05	0.00041	CcSEcCtD
Nilutamide—Cough—Topiramate—epilepsy syndrome	7.36e-05	0.000409	CcSEcCtD
Nilutamide—Feeling abnormal—Pregabalin—epilepsy syndrome	7.35e-05	0.000409	CcSEcCtD
Nilutamide—Paraesthesia—Gabapentin—epilepsy syndrome	7.35e-05	0.000409	CcSEcCtD
Nilutamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.29e-05	0.000406	CcSEcCtD
Nilutamide—Dyspnoea—Gabapentin—epilepsy syndrome	7.29e-05	0.000406	CcSEcCtD
Nilutamide—Hypertension—Topiramate—epilepsy syndrome	7.28e-05	0.000405	CcSEcCtD
Nilutamide—Dyspepsia—Gabapentin—epilepsy syndrome	7.2e-05	0.000401	CcSEcCtD
Nilutamide—Chest pain—Topiramate—epilepsy syndrome	7.18e-05	0.000399	CcSEcCtD
Nilutamide—Decreased appetite—Gabapentin—epilepsy syndrome	7.11e-05	0.000396	CcSEcCtD
Nilutamide—Discomfort—Topiramate—epilepsy syndrome	7.09e-05	0.000395	CcSEcCtD
Nilutamide—Asthenia—Valproic Acid—epilepsy syndrome	7.08e-05	0.000394	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.06e-05	0.000393	CcSEcCtD
Nilutamide—Abdominal pain—Pregabalin—epilepsy syndrome	7.05e-05	0.000392	CcSEcCtD
Nilutamide—Body temperature increased—Pregabalin—epilepsy syndrome	7.05e-05	0.000392	CcSEcCtD
Nilutamide—Dry mouth—Topiramate—epilepsy syndrome	7.02e-05	0.000391	CcSEcCtD
Nilutamide—Pain—Gabapentin—epilepsy syndrome	7e-05	0.000389	CcSEcCtD
Nilutamide—Constipation—Gabapentin—epilepsy syndrome	7e-05	0.000389	CcSEcCtD
Nilutamide—Pruritus—Valproic Acid—epilepsy syndrome	6.98e-05	0.000388	CcSEcCtD
Nilutamide—Oedema—Topiramate—epilepsy syndrome	6.88e-05	0.000383	CcSEcCtD
Nilutamide—Shock—Topiramate—epilepsy syndrome	6.77e-05	0.000377	CcSEcCtD
Nilutamide—Diarrhoea—Valproic Acid—epilepsy syndrome	6.75e-05	0.000376	CcSEcCtD
Nilutamide—Feeling abnormal—Gabapentin—epilepsy syndrome	6.74e-05	0.000375	CcSEcCtD
Nilutamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.69e-05	0.000372	CcSEcCtD
Nilutamide—Hyperhidrosis—Topiramate—epilepsy syndrome	6.65e-05	0.00037	CcSEcCtD
Nilutamide—Anorexia—Topiramate—epilepsy syndrome	6.56e-05	0.000365	CcSEcCtD
Nilutamide—Dizziness—Valproic Acid—epilepsy syndrome	6.53e-05	0.000363	CcSEcCtD
Nilutamide—Body temperature increased—Gabapentin—epilepsy syndrome	6.47e-05	0.00036	CcSEcCtD
Nilutamide—Abdominal pain—Gabapentin—epilepsy syndrome	6.47e-05	0.00036	CcSEcCtD
Nilutamide—Asthenia—Pregabalin—epilepsy syndrome	6.4e-05	0.000356	CcSEcCtD
Nilutamide—Pruritus—Pregabalin—epilepsy syndrome	6.31e-05	0.000351	CcSEcCtD
Nilutamide—Vomiting—Valproic Acid—epilepsy syndrome	6.27e-05	0.000349	CcSEcCtD
Nilutamide—Insomnia—Topiramate—epilepsy syndrome	6.22e-05	0.000346	CcSEcCtD
Nilutamide—Rash—Valproic Acid—epilepsy syndrome	6.22e-05	0.000346	CcSEcCtD
Nilutamide—Dermatitis—Valproic Acid—epilepsy syndrome	6.22e-05	0.000346	CcSEcCtD
Nilutamide—Headache—Valproic Acid—epilepsy syndrome	6.18e-05	0.000344	CcSEcCtD
Nilutamide—Paraesthesia—Topiramate—epilepsy syndrome	6.18e-05	0.000344	CcSEcCtD
Nilutamide—Dyspnoea—Topiramate—epilepsy syndrome	6.14e-05	0.000341	CcSEcCtD
Nilutamide—Diarrhoea—Pregabalin—epilepsy syndrome	6.1e-05	0.00034	CcSEcCtD
Nilutamide—Dyspepsia—Topiramate—epilepsy syndrome	6.06e-05	0.000337	CcSEcCtD
Nilutamide—Decreased appetite—Topiramate—epilepsy syndrome	5.98e-05	0.000333	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.94e-05	0.000331	CcSEcCtD
Nilutamide—Dizziness—Pregabalin—epilepsy syndrome	5.9e-05	0.000328	CcSEcCtD
Nilutamide—Constipation—Topiramate—epilepsy syndrome	5.88e-05	0.000327	CcSEcCtD
Nilutamide—Pain—Topiramate—epilepsy syndrome	5.88e-05	0.000327	CcSEcCtD
Nilutamide—Asthenia—Gabapentin—epilepsy syndrome	5.87e-05	0.000327	CcSEcCtD
Nilutamide—Nausea—Valproic Acid—epilepsy syndrome	5.86e-05	0.000326	CcSEcCtD
Nilutamide—Pruritus—Gabapentin—epilepsy syndrome	5.79e-05	0.000322	CcSEcCtD
Nilutamide—Vomiting—Pregabalin—epilepsy syndrome	5.67e-05	0.000316	CcSEcCtD
Nilutamide—Feeling abnormal—Topiramate—epilepsy syndrome	5.67e-05	0.000316	CcSEcCtD
Nilutamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.63e-05	0.000313	CcSEcCtD
Nilutamide—Rash—Pregabalin—epilepsy syndrome	5.62e-05	0.000313	CcSEcCtD
Nilutamide—Dermatitis—Pregabalin—epilepsy syndrome	5.62e-05	0.000313	CcSEcCtD
Nilutamide—Diarrhoea—Gabapentin—epilepsy syndrome	5.6e-05	0.000311	CcSEcCtD
Nilutamide—Headache—Pregabalin—epilepsy syndrome	5.59e-05	0.000311	CcSEcCtD
Nilutamide—Body temperature increased—Topiramate—epilepsy syndrome	5.44e-05	0.000303	CcSEcCtD
Nilutamide—Abdominal pain—Topiramate—epilepsy syndrome	5.44e-05	0.000303	CcSEcCtD
Nilutamide—Dizziness—Gabapentin—epilepsy syndrome	5.41e-05	0.000301	CcSEcCtD
Nilutamide—Nausea—Pregabalin—epilepsy syndrome	5.3e-05	0.000295	CcSEcCtD
Nilutamide—Vomiting—Gabapentin—epilepsy syndrome	5.2e-05	0.000289	CcSEcCtD
Nilutamide—Rash—Gabapentin—epilepsy syndrome	5.16e-05	0.000287	CcSEcCtD
Nilutamide—Dermatitis—Gabapentin—epilepsy syndrome	5.15e-05	0.000287	CcSEcCtD
Nilutamide—Headache—Gabapentin—epilepsy syndrome	5.12e-05	0.000285	CcSEcCtD
Nilutamide—Asthenia—Topiramate—epilepsy syndrome	4.94e-05	0.000275	CcSEcCtD
Nilutamide—Pruritus—Topiramate—epilepsy syndrome	4.87e-05	0.000271	CcSEcCtD
Nilutamide—Nausea—Gabapentin—epilepsy syndrome	4.86e-05	0.00027	CcSEcCtD
Nilutamide—Diarrhoea—Topiramate—epilepsy syndrome	4.71e-05	0.000262	CcSEcCtD
Nilutamide—Dizziness—Topiramate—epilepsy syndrome	4.55e-05	0.000253	CcSEcCtD
Nilutamide—Vomiting—Topiramate—epilepsy syndrome	4.38e-05	0.000243	CcSEcCtD
Nilutamide—Rash—Topiramate—epilepsy syndrome	4.34e-05	0.000241	CcSEcCtD
Nilutamide—Dermatitis—Topiramate—epilepsy syndrome	4.34e-05	0.000241	CcSEcCtD
Nilutamide—Headache—Topiramate—epilepsy syndrome	4.31e-05	0.00024	CcSEcCtD
Nilutamide—Nausea—Topiramate—epilepsy syndrome	4.09e-05	0.000227	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	3.21e-05	0.00112	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.19e-05	0.00111	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.17e-05	0.00111	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	3.13e-05	0.00109	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	3.13e-05	0.00109	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	3.12e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.07e-05	0.00107	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	3.04e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	3.03e-05	0.00106	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.01e-05	0.00105	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.99e-05	0.00105	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.99e-05	0.00105	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.98e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.93e-05	0.00102	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.88e-05	0.00101	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	2.86e-05	0.001	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	2.86e-05	0.000999	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA13—epilepsy syndrome	2.84e-05	0.000994	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SNRPE—epilepsy syndrome	2.8e-05	0.000979	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.8e-05	0.000978	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.73e-05	0.000954	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	2.72e-05	0.000951	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.66e-05	0.000929	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.65e-05	0.000927	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	2.65e-05	0.000926	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.63e-05	0.000918	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.62e-05	0.000914	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	2.59e-05	0.000906	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.58e-05	0.000902	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA13—epilepsy syndrome	2.54e-05	0.000887	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.39e-05	0.000834	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	2.33e-05	0.000816	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.32e-05	0.000809	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.31e-05	0.000809	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.29e-05	0.0008	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.27e-05	0.000794	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.26e-05	0.000788	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADK—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PDXK—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GLUD1—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FAR1—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—L2HGDH—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CERS1—epilepsy syndrome	2.15e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.04e-05	0.000714	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EPM2A—epilepsy syndrome	1.97e-05	0.000689	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PNPO—epilepsy syndrome	1.97e-05	0.000689	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GAMT—epilepsy syndrome	1.97e-05	0.000689	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NHLRC1—epilepsy syndrome	1.97e-05	0.000689	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EIF2S1—epilepsy syndrome	1.95e-05	0.000683	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.93e-05	0.000676	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PDXK—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CERS1—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FAR1—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADK—epilepsy syndrome	1.92e-05	0.000672	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPB1—epilepsy syndrome	1.89e-05	0.000659	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.86e-05	0.000651	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA4—epilepsy syndrome	1.83e-05	0.00064	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—QDPR—epilepsy syndrome	1.83e-05	0.00064	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—epilepsy syndrome	1.83e-05	0.000638	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.76e-05	0.000615	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.76e-05	0.000615	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.76e-05	0.000615	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.76e-05	0.000615	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.75e-05	0.000613	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	1.74e-05	0.000607	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—COX3—epilepsy syndrome	1.72e-05	0.000602	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.64e-05	0.000572	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.64e-05	0.000572	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CACNA2D2—epilepsy syndrome	1.63e-05	0.000571	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PFKL—epilepsy syndrome	1.63e-05	0.000571	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLCO1A2—epilepsy syndrome	1.63e-05	0.000571	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—KCNB1—epilepsy syndrome	1.63e-05	0.000571	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC6A8—epilepsy syndrome	1.63e-05	0.000571	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.63e-05	0.00057	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.6e-05	0.000561	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.6e-05	0.000561	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.6e-05	0.000561	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.6e-05	0.000561	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.6e-05	0.000558	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.59e-05	0.000554	CbGpPWpGaD
Nilutamide—AR—Gene Expression—JUNB—epilepsy syndrome	1.57e-05	0.00055	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.54e-05	0.000537	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.49e-05	0.000522	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.49e-05	0.000522	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.49e-05	0.000522	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.49e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.49e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.49e-05	0.000519	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.46e-05	0.000509	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.46e-05	0.000509	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.46e-05	0.000509	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.46e-05	0.000509	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.46e-05	0.000509	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.44e-05	0.000503	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.44e-05	0.000502	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.42e-05	0.000495	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.4e-05	0.00049	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.39e-05	0.000485	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.39e-05	0.000485	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.36e-05	0.000474	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.33e-05	0.000466	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.33e-05	0.000466	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.33e-05	0.000466	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.33e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.33e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.33e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.33e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.33e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	1.31e-05	0.000456	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.3e-05	0.000454	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.29e-05	0.000451	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.28e-05	0.000448	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	1.27e-05	0.000444	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SIRT1—epilepsy syndrome	1.27e-05	0.000443	CbGpPWpGaD
Nilutamide—AR—Gene Expression—VDR—epilepsy syndrome	1.25e-05	0.000436	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.24e-05	0.000433	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.24e-05	0.000433	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NT5E—epilepsy syndrome	1.24e-05	0.000432	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALAD—epilepsy syndrome	1.24e-05	0.000432	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.22e-05	0.000425	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.22e-05	0.000425	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.22e-05	0.000425	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.21e-05	0.000423	CbGpPWpGaD
Nilutamide—AR—Gene Expression—H2AFX—epilepsy syndrome	1.18e-05	0.000414	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	1.18e-05	0.000413	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	1.18e-05	0.000413	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.17e-05	0.000409	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.17e-05	0.000407	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-05	0.000404	CbGpPWpGaD
Nilutamide—AR—Gene Expression—YWHAZ—epilepsy syndrome	1.14e-05	0.000399	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	1.13e-05	0.000396	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADSL—epilepsy syndrome	1.13e-05	0.000396	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.13e-05	0.000395	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.13e-05	0.000395	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—epilepsy syndrome	1.12e-05	0.000393	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GLUL—epilepsy syndrome	1.11e-05	0.000388	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	1.1e-05	0.000386	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	1.1e-05	0.000386	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.1e-05	0.000386	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	1.09e-05	0.000381	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.06e-05	0.000371	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	1.05e-05	0.000368	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	1.05e-05	0.000368	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.03e-05	0.000361	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	1.03e-05	0.00036	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	1.02e-05	0.000356	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	1.01e-05	0.000353	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.01e-05	0.000352	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.01e-05	0.000352	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	9.91e-06	0.000346	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AQP1—epilepsy syndrome	9.89e-06	0.000346	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	9.72e-06	0.00034	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.61e-06	0.000336	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.61e-06	0.000336	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.5e-06	0.000332	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	9.4e-06	0.000329	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	9.21e-06	0.000322	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	9.1e-06	0.000318	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	9.03e-06	0.000316	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	8.95e-06	0.000313	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	8.95e-06	0.000313	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.87e-06	0.00031	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	8.83e-06	0.000309	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.48e-06	0.000296	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.33e-06	0.000291	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	8.29e-06	0.00029	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.16e-06	0.000285	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	8.05e-06	0.000281	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	7.99e-06	0.000279	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	7.99e-06	0.000279	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.73e-06	0.00027	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.44e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	7.29e-06	0.000255	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.29e-06	0.000255	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	7.28e-06	0.000254	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	7.28e-06	0.000254	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	7.11e-06	0.000248	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	7.06e-06	0.000247	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.01e-06	0.000245	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.78e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.64e-06	0.000232	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	6.51e-06	0.000228	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.39e-06	0.000223	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	6.38e-06	0.000223	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	6.31e-06	0.00022	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.26e-06	0.000219	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	6.07e-06	0.000212	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BCHE—epilepsy syndrome	6.04e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.94e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.78e-06	0.000202	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	5.77e-06	0.000201	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.75e-06	0.000201	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.71e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.71e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	5.7e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.69e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TH—epilepsy syndrome	5.68e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.59e-06	0.000195	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	5.42e-06	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	5.39e-06	0.000189	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.2e-06	0.000182	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.19e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	5.15e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	5.09e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TH—epilepsy syndrome	5.07e-06	0.000177	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.99e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.94e-06	0.000173	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.92e-06	0.000172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	4.74e-06	0.000166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.69e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAT—epilepsy syndrome	4.68e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.64e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TH—epilepsy syndrome	4.62e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.55e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	4.55e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	4.23e-06	0.000148	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.23e-06	0.000148	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	4.18e-06	0.000146	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	4.06e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.86e-06	0.000135	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.81e-06	0.000133	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.78e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGT—epilepsy syndrome	3.71e-06	0.00013	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.7e-06	0.000129	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—epilepsy syndrome	3.64e-06	0.000127	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.44e-06	0.00012	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—epilepsy syndrome	3.44e-06	0.00012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.31e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.25e-06	0.000113	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.12e-06	0.000109	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.02e-06	0.000106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.96e-06	0.000103	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.85e-06	9.95e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.79e-06	9.74e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.54e-06	8.88e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.54e-06	8.88e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.49e-06	8.71e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.32e-06	8.1e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.22e-06	7.77e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.03e-06	7.09e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.25e-06	4.38e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.12e-06	3.91e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.02e-06	3.56e-05	CbGpPWpGaD
